Your browser doesn't support javascript.
loading
Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania.
Zwyer, Michaela; Rutaihwa, Liliana K; Windels, Etthel; Hella, Jerry; Menardo, Fabrizio; Sasamalo, Mohamed; Sommer, Gregor; Schmülling, Lena; Borrell, Sonia; Reinhard, Miriam; Dötsch, Anna; Hiza, Hellen; Stritt, Christoph; Sikalengo, George; Fenner, Lukas; De Jong, Bouke C; Kato-Maeda, Midori; Jugheli, Levan; Ernst, Joel D; Niemann, Stefan; Jeljeli, Leila; Ballif, Marie; Egger, Matthias; Rakotosamimanana, Niaina; Yeboah-Manu, Dorothy; Asare, Prince; Malla, Bijaya; Dou, Horng Yunn; Zetola, Nicolas; Wilkinson, Robert J; Cox, Helen; Carter, E Jane; Gnokoro, Joachim; Yotebieng, Marcel; Gotuzzo, Eduardo; Abimiku, Alash'le; Avihingsanon, Anchalee; Xu, Zhi Ming; Fellay, Jacques; Portevin, Damien; Reither, Klaus; Stadler, Tanja; Gagneux, Sebastien; Brites, Daniela.
Afiliação
  • Zwyer M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Rutaihwa LK; University of Basel, Basel, Switzerland.
  • Windels E; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Hella J; University of Basel, Basel, Switzerland.
  • Menardo F; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Sasamalo M; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
  • Sommer G; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Schmülling L; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Borrell S; Department of Plant and Microbial Biology, University of Zürich, Zürich, Switzerland.
  • Reinhard M; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Dötsch A; Institut für Radiologie und Nuklearmedizin, Hirslanden Klinik St. Anna, Luzern, Switzerland.
  • Hiza H; Klinik für Radiologie und Nuklearmedizin, Department Theragnostik, Universitätsspital Basel, Basel, Switzerland.
  • Stritt C; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Sikalengo G; University of Basel, Basel, Switzerland.
  • Fenner L; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • De Jong BC; University of Basel, Basel, Switzerland.
  • Kato-Maeda M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Jugheli L; University of Basel, Basel, Switzerland.
  • Ernst JD; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Niemann S; University of Basel, Basel, Switzerland.
  • Jeljeli L; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Ballif M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Egger M; University of Basel, Basel, Switzerland.
  • Rakotosamimanana N; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
  • Yeboah-Manu D; St. Francis Referral Hospital, Ifakara, Tanzania.
  • Asare P; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Malla B; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Dou HY; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America.
  • Zetola N; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Wilkinson RJ; University of Basel, Basel, Switzerland.
  • Cox H; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, United States.
  • Carter EJ; Molecular and Experimental Mycobacteriology, Borstel Research Centre, Borstel, Germany.
  • Gnokoro J; Molecular and Experimental Mycobacteriology, Borstel Research Centre, Borstel, Germany.
  • Yotebieng M; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Gotuzzo E; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Abimiku A; Centre for Infectious Disease Research and Epidemiology, University of Cape Town, Cape Town, South Africa.
  • Avihingsanon A; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Xu ZM; Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Fellay J; Bacteriology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
  • Portevin D; Bacteriology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
  • Reither K; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Stadler T; University of Basel, Basel, Switzerland.
  • Gagneux S; National Institute of Infectious Diseases and Vaccinology, National Health Research Institute, Zhunan, Taiwan.
  • Brites D; Botswana-UPenn Partnership, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
PLoS Pathog ; 19(4): e1010893, 2023 04.
Article em En | MEDLINE | ID: mdl-37014917
In settings with high tuberculosis (TB) endemicity, distinct genotypes of the Mycobacterium tuberculosis complex (MTBC) often differ in prevalence. However, the factors leading to these differences remain poorly understood. Here we studied the MTBC population in Dar es Salaam, Tanzania over a six-year period, using 1,082 unique patient-derived MTBC whole-genome sequences (WGS) and associated clinical data. We show that the TB epidemic in Dar es Salaam is dominated by multiple MTBC genotypes introduced to Tanzania from different parts of the world during the last 300 years. The most common MTBC genotypes deriving from these introductions exhibited differences in transmission rates and in the duration of the infectious period, but little differences in overall fitness, as measured by the effective reproductive number. Moreover, measures of disease severity and bacterial load indicated no differences in virulence between these genotypes during active TB. Instead, the combination of an early introduction and a high transmission rate accounted for the high prevalence of L3.1.1, the most dominant MTBC genotype in this setting. Yet, a longer co-existence with the host population did not always result in a higher transmission rate, suggesting that distinct life-history traits have evolved in the different MTBC genotypes. Taken together, our results point to bacterial factors as important determinants of the TB epidemic in Dar es Salaam.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis País/Região como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis País/Região como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça